BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260604T151840EDT-1958eU7imW@132.216.98.100
DTSTAMP:20260604T191840Z
DESCRIPTION:The 91ºÚÁÏÍø Research Group on Health and Law (RGHL) is pleased t
 o invite you to its 2015 Annual Lecture on Health and Law with Trudo Lemme
 ns\, Professor and Scholl Chair in Health Law and Policy at the University
  of Toronto Faculty of Law. \nAbstract\nSince Thalidomide\, the legal regi
 me introduced to improve pharmaceutical product safety and efficacy has ge
 nerated new administrative\, industrial and scientific practices.  These p
 ractices\, in combination with a host of social\, cultural and scientific 
 developments\, including the emphasis on evidence-based medicine\, have st
 rengthened industry’s grip over pharmaceutical knowledge production. Statu
 tory law and regulation have thereby facilitated fraud and misrepresentati
 on\, while industry’s growing control over scientific knowledge has also u
 ndermined the integrity of traditional tort mechanisms that could offer co
 mpensation to those affected by these practices. Professor Lemmens will di
 scuss these developments and briefly explore the strength and limits of so
 me legal tools aimed at curbing this trend\, paying particular attention t
 o recent legal skirmishes related to transparency and access to data. Cons
 idering the central role of scientific knowledge and the impact of health 
 care products on physical and mental integrity\, he will argue that states
  have a human rights obligation to strengthen independent scientific knowl
 edge production.  \nBiography\nTrudo Lemmens is Professor and Scholl Chair
  in Health Law and Policy at the Faculty of Law of the University of Toron
 to\, with cross appointments in the Faculty of Medicine and the Joint Cent
 re for Bioethics. He holds a Licentiate in Law from the K.U.Leuven (Belgiu
 m) and both an LLM (bioethics) and Doctorate in Law (DCL) from 91ºÚÁÏÍø Univ
 ersity. Since joining the University of Toronto Faculty of Law\, he has be
 en a member of the School of Social Science of the Institute for Advanced 
 Study in Princeton\, a visiting fellow of the Royal Flemish Academy of Bel
 gium for Science and the Arts\, a visiting professor at the K.U.Leuven\, t
 he University of Otago (New Zealand) and the Centre for Transnational Lega
 l Studies\, a Plumer Visiting Fellow at Oxford’s St. Anne’s College\, and 
 an academic visitor of Oxford University's HeLEX Center for Health\, Law a
 nd Emerging Technologies. He has been a member of various provincial\, nat
 ional and international committees\, and is currently a member of the Advi
 sory Committee on Health Research of the Pan American Health Organization 
 and of the Board of the Ontario Mental Health Foundation. \nHis research a
 nd teaching is situated at the interface of law\, ethics\, and professiona
 l governance. His current research focuses on the complex interaction betw
 een law\, governance mechanisms\, and ethical norms and values in the cont
 ext of health care\, biomedical research\, health product development\, an
 d--more generally--knowledge production.\nA request for accreditation as a
  continuing legal education activity has been made to the Barreau du Québe
 c.\nKindly RSVP to rghl.law [at] mcgill.ca.\n
DTSTART:20150225T210000Z
DTEND:20150225T230000Z
LOCATION:Maxwell Cohen Moot Court (NCDH 100)\, Chancellor Day Hall\, CA\, Q
 C\, Montreal\, H3A 1W9\, 3644 rue Peel
SUMMARY:How Law Facilitated Pharmaceutical Fraud and How It Could Save Us
URL:/law/channels/event/how-law-facilitated-pharmaceut
 ical-fraud-and-how-it-could-save-us-241516
END:VEVENT
END:VCALENDAR